CXCR4 and breast carcinoma: TBMS I can also inhibit the invasion and metastasis of breast cancer MDA-MB-231 cells by downregulating the expression of CXCR4 or interrupting CXCL12-CXCR4 cell signal pathway (Peng et al., 2016).